N/A
N=456
A Chatbot Intervention for Reducing HPV Vaccine Hesitancy
Cervical Cancer · Anal Cancer · Penile Cancer
Bottom Line
View on ClinicalTrials.gov: NCT05959564 ↗Enrolled (actual)
456
Serious AEs
—
Results posted
Oct 2024
Primary outcome: Primary: Attitudes Toward HPV Vaccination — 3.86; 3.96; 3.41 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Personalized Chatbot Intervention (Behavioral); Non-Personalized Chatbot Intervention (Behavioral); No Chatbot Control (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Maryland, College Park
- Primary completion
- Aug 2023
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Attitudes Toward HPV Vaccination |
3.86; 3.96; 3.41 | — |
| PRIMARY Intentions Toward HPV Vaccination |
3.87; 3.95; 3.56 | — |
| SECONDARY Ratings of the Chatbot |
4.10; 4.16 | — |
Summary
The goal of this project is to test the efficacy of a chatbot intervention for reducing HPV vaccine hesitancy among African American parents. An online experiment will be conducted to test the effectiveness of the chatbot intervention with African American parents. Results of this project will inform future communication interventions for reducing vaccine hesitancy among African American parents.
Eligibility Criteria
Inclusion Criteria
- 18 years or older
- Self-identify as Black or African American
- Parents of children under 18 years old
- Access to computer/laptop/mobile device and the Internet
Exclusion Criteria
- Under 18 years
- Does not self-identify as Black or African American
- Not a parent of at least a child under 18 years old
- No access to computer/laptop/mobile device or the Internet
Data sourced from ClinicalTrials.gov (NCT05959564). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.